Use of xenogeneic islets in hybrid artificial pancreas for treatment of diabetes without immunosuppression

Transplant Proc. 1992 Apr;24(2):661-2.

Authors

H Ohzato¹, M Carretta, T Maki, S J Sullivan, K Borland, T E Muller, B A Solomon, W L Chick, A P Monaco

Affiliation

¹ Division of Organ Transplantation, New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02215.

PMID: 1566471

No abstract available

MeSH terms

Animals
Blood Glucose / metabolism
Body Weight
Cattle
Diabetes Mellitus, Experimental / blood
Diabetes Mellitus, Experimental / drug therapy
Diabetes Mellitus, Experimental / surgery*
Dogs
Female
Insulin Infusion Systems
Insulin, Long-Acting / therapeutic use
Islets of Langerhans Transplantation / methods*
Islets of Langerhans Transplantation / physiology
Pancreatectomy
Transplantation, Heterologous / methods
Transplantation, Heterologous / physiology

Substances

Blood Glucose
Insulin, Long-Acting